Publications by authors named "Shreyaskumar Patel"

Claim this Profile
P
Primary Synovial Sarcoma of the Abdomen and Pelvis.
Riddhi R Patel, Jonathan Feit, Grace Werling, Nora M White, Andrew J Bishop, Shreyaskumar R Patel

Am J Clin Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An adaptive transformer-based framework for advanced brain activity mapping and intelligent neurotherapeutic decision support.
Bhushankumar Nemade, Vikram Kulkarni, Deven Shah, Keyur Patel, Shreyaskumar Patel

Front Hum Neurosci· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AO Spine Clinical Practice Recommendations: Current Systemic Oncological Treatments with the Largest Impact on Patients with Metastatic Spinal Disease.
Marcin Czyz, Emerens G Wensink, Brian Coimbra, Michael Galgano, Shreyaskumar Patel

Global Spine J· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dedifferentiated liposarcomas treated with immune checkpoint blockade: the MD Anderson experience.
Madeline B Torres, Cheuk Hong Leung, Marianne Zoghbi, Rossana Lazcano, Davis Ingram, Shreyaskumar Patel

Front Immunol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TFCP2 Fusion-Positive Rhabdomyosarcomas: A Report of 10 Cases and a Review of the Literature.
Madison P Ginn, Ryan A Denu, Davis R Ingram, Khalida M Wani, Alexander J Lazar, Shreyaskumar Patel

Cancers (Basel)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary Intrathoracic Synovial Sarcoma: An Analysis of Outcomes of This Rare Disease.
Riddhi R Patel, Andrew J Bishop, Alexander J Lazar, Patrick P Lin, Robert S Benjamin, Shreyaskumar R Patel

Cancers (Basel)· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does the Primary Tumor Site Drive Biology for Patients With Synovial Sarcoma?
Riddhi R Patel, George L Delclos, Stacia M DeSantis, Michael B Cannell, Philip J Lupo, Shreyaskumar R Patel

Am J Clin Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Latest Developments in Targeted Biological Therapies in the Management of Chordoma and Chondrosarcoma.
Adam Biczo, Arjun Sahgal, Jorrit-Jan Verlaan, Patel Shreyaskumar, Zsolt Szoverfi

Global Spine J· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overview of Molecular Prognostication for Common Solid Tumor Histologies - What the Surgeon Should Know.
C Rory Goodwin, Rafael De la Garza Ramos, Chetan Bettegowda, Ori Barzilai, Patel Shreyaskumar

Global Spine J· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A short report on ADHD detection using convolutional neural networks.
Vikram Kulkarni, Bhushankumar Nemade, Shreyaskumar Patel, Keyur Patel, Srikanth Velpula

Front Psychiatry· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical characteristics and outcomes of adult alveolar rhabdomyosarcoma patients on first-line systemic therapies: A single-institution cohort.
Michael S Nakazawa, J Andrew Livingston, Maria A Zarzour, Andrew J Bishop, Ravin Ratan, Shreyaskumar R Patel

Rare Tumors· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss of the DNA Repair Gene RNase H2 Identifies a Unique Subset of DDR-Deficient Leiomyosarcomas.
Michael S Nakazawa, Ian M Silverman, Victoria Rimkunas, Artur Veloso, Dominik Glodzik, Shreyaskumar R Patel

Mol Cancer Ther· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of systemic therapy in advanced skull base chordomas: overview of the current state and the MD Anderson protocol.
Matei A Banu, Shaan M Raza, Misha Amini, Scott Seaman, Franco Rubino, Shreyaskumar Patel

Neurosurg Focus· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-Grade Pleomorphic Sarcomas Treated with Immune Checkpoint Blockade: The MD Anderson Cancer Center Experience.
Lewis F Nasr, Marianne Zoghbi, Rossana Lazcano, Michael Nakazawa, Andrew J Bishop, Shreyaskumar Patel

Cancers (Basel)· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma.
Christina L Roland, Elise F Nassif Haddad, Emily Z Keung, Wei-Lien Wang, Alexander J Lazar, Shreyaskumar Patel

Nat Cancer· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utility of Clinical Next Generation Sequencing Tests in KIT/PDGFRA/SDH Wild-Type Gastrointestinal Stromal Tumors.
Ryan A Denu, Cissimol P Joseph, Elizabeth S Urquiola, Precious S Byrd, Richard K Yang, Shreyaskumar Patel

Cancers (Basel)· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of Late-Line Systemic Treatment in GIST: Does Sequence Matter?
Prapassorn Thirasastr, Thomas L Sutton, Cissimol P Joseph, Heather Lin, Behrang Amini, Shreyaskumar Patel

Cancers (Basel)· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinico-Genomic Profiling of Conventional and Dedifferentiated Chondrosarcomas Reveals TP53 Mutation to Be Associated with Worse Outcomes.
Ryan A Denu, Richard K Yang, Alexander J Lazar, Shalin S Patel, Valerae O Lewis, Shreyaskumar Patel

Clin Cancer Res· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
Joint Adult and Pediatric Working Group as a Successful Platform to Strengthen Adolescent and Young Adult (AYA) Clinical Trial Collaboration: A Report from the NCTN/SARC AYA Clinical Trials Sarcoma Working Group.
Susan L Whiteway, Aaron R Weiss, Safia K Ahmed, Wendy A Allen-Rhoades, Viswatej Avutu, Shreyaskumar R Patel

J Adolesc Young Adult Oncol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Biomarker-Matched Therapies on Outcomes in Patients with Sarcoma Enrolled in Early-Phase Clinical Trials (SAMBA 101).
Roberto Carmagnani Pestana, Justin T Moyers, Jason Roszik, Shiraj Sen, David S Hong, Shreyaskumar R Patel

Clin Cancer Res· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized Phase II Trial of Sunitinib or Cediranib in Alveolar Soft Part Sarcoma.
James Nguyen, Naoko Takebe, Shivaani Kummar, Albiruni Razak, Sant P Chawla, Shreyaskumar R Patel

Clin Cancer Res· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retrospective evaluation of the role of gemcitabine-docetaxel in well-differentiated and dedifferentiated liposarcoma.
Prapassorn Thirasastr, Heather Lin, Behrang Amini, Wei-Lien Wang, Jeffrey M Cloutier, Shreyaskumar Patel

Cancer Med· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Examining Stripes on a Herd of Zebras: Impact of Genomic Matching for Ultrarare Sarcomas in Phase 1 Clinical Trials (SAMBA 102).
Justin T Moyers, Roberto Carmagnani Pestana, Jason Roszik, David S Hong, Aung Naing, Shreyaskumar Patel

Clin Cancer Res· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Best clinical management of tenosynovial giant cell tumour (TGCT): A consensus paper from the community of experts.
Silvia Stacchiotti, Hans Roland Dürr, Inga-Marie Schaefer, Klaus Woertler, Rick Haas, Shreyaskumar R Patel

Cancer Treat Rev· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The immune landscape of undifferentiated pleomorphic sarcoma.
Rossana Lazcano, Carmelia M Barreto, Ruth Salazar, Fernando Carapeto, Raymond S Traweek, Shreyaskumar Patel

Front Oncol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis